Pulse Biosciences (PLSE) EPS (Weighted Average and Diluted) (2021 - 2022)

Pulse Biosciences' quarterly EPS (Weighted Average and Diluted) came in at -$0.49 in Q3 2022, down 2.08% year-on-year from -$0.5 in Q3 2021, and down 11.36% quarter-over-quarter from -$0.44 in Q2 2022.

Pulse Biosciences has reported EPS (Weighted Average and Diluted) for 2 years, with the latest figure at -$0.49 in Q3 2022.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EPS (Weighted Avg. Diluted) (Qtr)
1 Intuitive Surgical 156.17 Bn 151.78 Bn 1.83 Bn 2.28
2 Becton Dickinson 41.51 Bn 40.49 Bn 2.15 Bn -1.11
3 Resmed 30.43 Bn 28.77 Bn 890.98 Mn 2.74
4 West Pharmaceutical Services 22.78 Bn 22.26 Bn 296.40 Mn 1.92
5 Solventum 13.39 Bn 13.39 Bn 1.10 Bn 0.07
6 Cooper Companies 12.33 Bn 12.20 Bn 695.20 Mn 0.66
7 Align Technology 11.65 Bn 10.59 Bn 736.59 Mn 1.57
8 Baxter International 9.81 Bn 7.77 Bn 891.00 Mn -0.03
9 Aptargroup 7.39 Bn 7.19 Bn 351.91 Mn 1.12
10 Pulse Biosciences 1.72 Bn 1.72 Bn - -

Historic Data

Download Data 🔒
DateValue
Sep 30, 2022 -0.49
Jun 30, 2022 -0.44
Sep 30, 2021 -0.48
Jun 30, 2021 -0.58